129 related articles for article (PubMed ID: 36202224)
1. Hypoxia promotes the expression of Von Willebrand factor in breast cancer cells by up-regulating the transcription factor YY1 and down-regulating the hsa-miR-424.
Tao Q; Lu Y; Qi Y; Yu D; Gu J; Zhu Y; Shi C; Liang X
Eur J Pharmacol; 2022 Nov; 934():175308. PubMed ID: 36202224
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer cells-derived Von Willebrand Factor promotes VEGF-A-related angiogenesis through PI3K/Akt-miR-205-5p signaling pathway.
Tao Q; Qi Y; Gu J; Yu D; Lu Y; Liu J; Liang X
Toxicol Appl Pharmacol; 2022 Apr; 440():115927. PubMed ID: 35192807
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells.
Mojiri A; Nakhaii-Nejad M; Phan WL; Kulak S; Radziwon-Balicka A; Jurasz P; Michelakis E; Jahroudi N
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1329-38. PubMed ID: 23580145
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia.
Mojiri A; Alavi P; Lorenzana Carrillo MA; Nakhaei-Nejad M; Sergi CM; Thebaud B; Aird WC; Jahroudi N
Atherosclerosis; 2019 Mar; 282():1-10. PubMed ID: 30665023
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration.
Dhami SPS; Patmore S; Comerford C; Byrne CM; Cavanagh B; Castle J; Kirwan CC; Kenny M; Schoen I; O'Donnell JS; O'Sullivan JM
J Thromb Haemost; 2022 Oct; 20(10):2350-2365. PubMed ID: 35722954
[TBL] [Abstract][Full Text] [Related]
6. Dual Targeting of Angipoietin-1 and von Willebrand Factor by microRNA-671-5p Attenuates Liver Angiogenesis and Fibrosis.
Yang L; Yue W; Zhang H; Zhang Z; Xue R; Dong C; Liu F; Chang N; Yang L; Li L
Hepatol Commun; 2022 Jun; 6(6):1425-1442. PubMed ID: 35014213
[TBL] [Abstract][Full Text] [Related]
7. Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis.
Wang AM; Huang TT; Hsu KW; Huang KH; Fang WL; Yang MH; Lo SS; Chi CW; Lin JJ; Yeh TS
Oncotarget; 2014 Jul; 5(13):5002-16. PubMed ID: 24970812
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
[TBL] [Abstract][Full Text] [Related]
10. Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.
Nassiri M; Liu J; Kulak S; Uwiera RR; Aird WC; Ballermann BJ; Jahroudi N
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1423-9. PubMed ID: 20431063
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level.
Qian S; Wang W; Li M
Biomed Pharmacother; 2020 Jun; 126():110085. PubMed ID: 32199224
[TBL] [Abstract][Full Text] [Related]
12. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
[TBL] [Abstract][Full Text] [Related]
13. The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer.
Zuo Y; Qu C; Tian Y; Wen Y; Xia S; Ma M
Biofactors; 2021 May; 47(3):444-460. PubMed ID: 34003544
[TBL] [Abstract][Full Text] [Related]
14. The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.
Lieberthal JG; Kaminsky M; Parkhurst CN; Tanese N
Breast Cancer Res; 2009; 11(3):R42. PubMed ID: 19566924
[TBL] [Abstract][Full Text] [Related]
15. Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice.
Kleinschmidt AM; Nassiri M; Stitt MS; Wasserloos K; Watkins SC; Pitt BR; Jahroudi N
J Biol Chem; 2008 Feb; 283(5):2741-50. PubMed ID: 18048367
[TBL] [Abstract][Full Text] [Related]
16. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
17. Effect of lncRNA-ATB/miR-651-3p/Yin Yang 1 pathway on trophoblast-endothelial cell interaction networks.
Yin Y; Zhang J; Yu H; Liu M; Zheng X; Zhou R
J Cell Mol Med; 2021 Jun; 25(12):5391-5403. PubMed ID: 33942988
[TBL] [Abstract][Full Text] [Related]
18. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis.
Zanetta L; Marcus SG; Vasile J; Dobryansky M; Cohen H; Eng K; Shamamian P; Mignatti P
Int J Cancer; 2000 Jan; 85(2):281-8. PubMed ID: 10629090
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
[No Abstract] [Full Text] [Related]
20. Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.
Infante T; Mancini FP; Lanza A; Soricelli A; de Nigris F; Napoli C
Biochim Biophys Acta; 2015 May; 1853(5):975-86. PubMed ID: 25644713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
